Viewing Study NCT05002816


Ignite Creation Date: 2025-12-26 @ 11:47 AM
Ignite Modification Date: 2025-12-26 @ 11:47 AM
Study NCT ID: NCT05002816
Status: RECRUITING
Last Update Posted: 2025-10-30
First Post: 2021-07-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
Sponsor: Yale University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module